Evidence map›Paper›PMID 25294880›Full record

ArticleThe Journal of biological chemistry2014

Biochemical and biophysical characterization of an unexpected bacteriolytic activity of VanX, a member of the vancomycin-resistance vanA gene cluster.

Shihori Sohya, Tetsuya Kamioka, Chisako Fujita, Tei Maki, Yoshihiro Ohta, Yutaka Kuroda

Abstract read
In one paragraph

Article in The Journal of biological chemistry, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Review
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Shihori SohyaFrom the Department of Biotechnology and Life Science, Graduate School of Engineering, and.
Tetsuya KamiokaFrom the Department of Biotechnology and Life Science, Graduate School of Engineering, and.
Chisako FujitaFrom the Department of Biotechnology and Life Science, Graduate School of Engineering, and.
Tei MakiResearch Center for Science and Technology, Tokyo University of Agriculture and Technology, 2-24-16 Nakamachi, Koganei-shi, Tokyo, 184-8588 Japan, and JEOL Ltd., EM Business Unit, 3-1-2 Musashino, Akishima, Tokyo 196-8558, Japan.
Yoshihiro OhtaFrom the Department of Biotechnology and Life Science, Graduate School of Engineering, and.
Yutaka KurodaFrom the Department of Biotechnology and Life Science, Graduate School of Engineering, and ykuroda@cc.tuat.ac.jp.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

VanX is a d-alanyl-d-alanine (d-Ala-d-Ala) dipeptidase encoded in the vancomycin-resistance vanA gene cluster. Here we report that strong bacteriolysis occurred when isolated VanX was expressed in Escherichia coli at temperatures lower than 30 °C, which was unexpected because the vanA operon confers vancomycin resistance by protecting the cell wall. Therefore, we monitored cell lysis by measuring sample turbidity with absorbance at 590 nm and VanX expression using SDS-PAGE. No cell lysis was observed when VanX was expressed, even in large quantities, in the cell inclusion bodies at 37 °C, suggesting that a natively folded VanX is required for lysis. In addition, VanX mutants with suppressed dipeptidase activity did not lyse E. coli cells, confirming that bacteriolysis originated from the dipeptidase activity of VanX. We also observed shape changes in E. coli cells undergoing VanX-mediated lysis with optical microscopy and classified these changes into three classes: bursting, deformation, and leaking fluid. Optical microscopic image analysis fully corroborated our interpretation of the turbidity changes in the samples. From a practical perspective, the finding that VanX expressed in isolation induces cell lysis suggests that inhibitors of VanA and VanH that act downstream from VanX could provide a new class of therapeutic chemicals against bacteria expressing the vancomycin-resistance gene cluster.

Indexed as

Bacterial ProteinsBacteriolysisEscherichia coliGenes, BacterialMultigene FamilyProtein Structure, SecondarySerine-Type D-Ala-D-Ala CarboxypeptidaseVancomycin ResistanceBacterial ProteinsSerine-Type D-Ala-D-Ala CarboxypeptidaseVanX dipeptidaseAntibiotic ResistanceBacterial PathogenesisCell WallMureinPeptidasePeptidoglycan

Identifiers

PMID25294880
PMCPMC4276839

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.